ORGS

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 9/18/2017
Contact Info
  • 20271 Goldenrod Lane
  • Germantown, MD 20876

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Aug 31, 2017 10-Q
CIK 0001460602
Fiscal Year End 11/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. Not Available
Employees 80 a/o Nov 30, 2016
Company Officers/Contacts
Vered Caplan CEO
Neil Reithinger CFO, Treasurer, Secretary
Company Directors
Vered Caplan Chairman
Yaron Adler Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
Hugues Bultot
Ashish Nanda
Dr. David Sidransky Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
Guy Yachin
Service Providers
Accounting/Auditing Firm
PricewaterhouseCoopers LLP
300 Madison Avenue
24th Floor
New York, NY, 10017
United States
 
Eventus Advisory Group, LLC
14201 N. Hayden Road
Suite A-1
Scottsdale, 85260
United States
 
Securities Counsel
Clark Wilson LLP OTCQX Sponsor
885 West Georgia Street
Suite 900
Vancouver, BC, V6C 3H1
Canada
 
Investor Relations Firm

Not Available
Company History
  • Formerly=Business Outsourcing Services, Inc. until 9-2011
ORGS Security Details
Share Structure
Market Value1 $44,822,205 a/o Oct 19, 2017
Authorized Shares 1,750,000,000 a/o Oct 13, 2016
Outstanding Shares 121,779,252 a/o Oct 16, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 70,250,000 a/o Oct 13, 2016
Par Value 0.001
Shareholders
Shareholders of Record 67 a/o Feb 28, 2017
Short Selling Data
Short Interest 602 (-91.66%)
Sep 29, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security